Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB - Get Free Report) is projected to post its Q2 2025 quarterly earnings results after the market closes on Wednesday, July 23rd. Analysts expect Core Laboratories to post earnings of $0.18 per share and revenue of $129.19 million for the quarter. Core Laboratories has set its Q2 2025 guidance at 0.170-0.210 EPS.

Core Laboratories (NYSE:CLB - Get Free Report) last announced its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). The firm had revenue of $123.59 million for the quarter, compared to analysts' expectations of $125.09 million. Core Laboratories had a net margin of 5.41% and a return on equity of 15.06%. The company's quarterly revenue was down 4.7% on a year-over-year basis. During the same period in the previous year, the company earned $0.19 EPS. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Trading Down 2.1%

Shares of NYSE:CLB traded down $0.24 on Friday, hitting $11.41. The company had a trading volume of 298,756 shares, compared to its average volume of 407,983. The firm's 50-day simple moving average is $11.83 and its two-hundred day simple moving average is $14.11. Core Laboratories has a 1 year low of $10.14 and a 1 year high of $25.13. The company has a quick ratio of 1.64, a current ratio of 2.21 and a debt-to-equity ratio of 0.48. The firm has a market capitalization of $534.90 million, a price-to-earnings ratio of 19.34, a P/E/G ratio of 3.58 and a beta of 1.41.

Core Laboratories Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Monday, May 5th were given a $0.01 dividend. The ex-dividend date was Monday, May 5th. This represents a $0.04 annualized dividend and a dividend yield of 0.35%. Core Laboratories's dividend payout ratio is 6.78%.

Analysts Set New Price Targets

A number of brokerages have recently commented on CLB. Wall Street Zen lowered shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Citigroup cut their target price on shares of Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research report on Tuesday, May 13th. Finally, Stifel Nicolaus cut their target price on shares of Core Laboratories from $13.00 to $12.00 and set a "hold" rating for the company in a research report on Wednesday.

Institutional Inflows and Outflows

An institutional investor recently raised its position in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.4% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 27,893 shares of the oil and gas company's stock after purchasing an additional 1,170 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned 0.06% of Core Laboratories worth $418,000 as of its most recent filing with the Securities & Exchange Commission. Institutional investors and hedge funds own 97.81% of the company's stock.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.